All In Biotech

Drug Trial Radar · NCT00266487

The Norwegian Vitamin Trial (NORVIT)

Randomized Trial of Homocysteine-lowering With B Vitamins for Secondary Prevention of Cardiovascular Disease After Acute Myocardial Infarction. The Norwegian Vitamin Trial (NORVIT)

Last checked: Nov 20, 2026Latest source record: May 8, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 3,750 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,750

Actual

Start

Dec 1998

Primary completion

Not stated

Study completion Mar 2004

Sponsor

Lead sponsor
University of TromsoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The Research Council of Norway; The Council on Health and Rehabilitation, Norway; The Norwegian Council on Cardiovascular Disease; The Royal Norwegian Ministry of Health; The International Federation of Red Cross and Red Crescent Societies; Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway
First posted
Dec 16, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Factorial
Masking
Double
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 30 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to examine whether the lowering of blood homocysteine levels by treatment with B vitamins can prevent cardiovascular disease

Conditions

  • Acute Myocardial Infarction

Interventions

  • Folic acidDrug

  • Vitamin B12Drug

  • Vitamin B6Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary end point was a composite of
  2. nonfatal myocardial infarction,
  3. fatal myocardial infarction,
  4. nonfatal stroke,
  5. fatal stroke, and
  6. sudden death attributed to coronary heart disease.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Institute of Community Medicine, University of Tromsø

    Tromsø, Norway

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.